These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25894292)

  • 21. [Immunological and endocrinological pattern in ADHD etiopathogenesis].
    Budziszewska B; Basta-Kaim A; Kubera M; Lasoń W
    Przegl Lek; 2010; 67(11):1200-4. PubMed ID: 21442976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autonomic correlates at rest and during evoked attention in children with attention-deficit/hyperactivity disorder and effects of methylphenidate.
    Negrao BL; Bipath P; van der Westhuizen D; Viljoen M
    Neuropsychobiology; 2011; 63(2):82-91. PubMed ID: 21178382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pozanicline for the treatment of attention-deficit/hyperactivity disorder.
    Childress A; Sallee FR
    Expert Opin Investig Drugs; 2014 Nov; 23(11):1585-93. PubMed ID: 25196198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Collicular dysfunction in attention deficit hyperactivity disorder.
    Overton PG
    Med Hypotheses; 2008; 70(6):1121-7. PubMed ID: 18215471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The neuropsychopharmacology of attention-deficit/hyperactivity disorder.
    Pliszka SR
    Biol Psychiatry; 2005 Jun; 57(11):1385-90. PubMed ID: 15950012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated Melatonin Levels in Children With Attention Deficit Hyperactivity Disorder: Relationship to Oxidative and Nitrosative Stress.
    Avcil S; Uysal P; Yenisey Ç; Abas BI
    J Atten Disord; 2021 Mar; 25(5):693-703. PubMed ID: 30819002
    [No Abstract]   [Full Text] [Related]  

  • 27. The potential for misuse and abuse of medications in ADHD: a review.
    Clemow DB; Walker DJ
    Postgrad Med; 2014 Sep; 126(5):64-81. PubMed ID: 25295651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth deficits in children with attention deficit hyperactivity disorder.
    Spencer T; Biederman J; Wilens T
    Pediatrics; 1998 Aug; 102(2 Pt 3):501-6. PubMed ID: 9685453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidative injury in epilepsy: potential for antioxidant therapy?
    Costello DJ; Delanty N
    Expert Rev Neurother; 2004 May; 4(3):541-53. PubMed ID: 15853548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).
    NIH Consens Statement; 1998 Nov 16-18; 16(2):1-37. PubMed ID: 10868163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Biochemical bases and research in attention-deficit hyperactivity disorder].
    Díaz-Heijtz R
    Rev Neurol; 2002 Feb; 34 Suppl 1():S78-81. PubMed ID: 12447795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sofinicline: a novel nicotinic acetylcholine receptor agonist in the treatment of attention-deficit/hyperactivity disorder.
    Fleisher C; McGough J
    Expert Opin Investig Drugs; 2014 Aug; 23(8):1157-63. PubMed ID: 24965900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary catecholamines in children with attention deficit hyperactivity disorder (ADHD): modulation by a polyphenolic extract from pine bark (pycnogenol).
    Dvoráková M; Jezová D; Blazícek P; Trebatická J; Skodácek I; Suba J; Iveta W; Rohdewald P; Duracková Z
    Nutr Neurosci; 2007; 10(3-4):151-7. PubMed ID: 18019397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Catecholamine dysfunction in attention-deficit/hyperactivity disorder: an update.
    Prince J
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S39-45. PubMed ID: 18480676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced salivary cortisol in children with comorbid Attention deficit hyperactivity disorder and oppositional defiant disorder.
    Kariyawasam SH; Zaw F; Handley SL
    Neuro Endocrinol Lett; 2002 Feb; 23(1):45-8. PubMed ID: 11880861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Attention Deficit Hyperactivity Disorder (ADHD) and Polyphenols: A Systematic Review.
    Turiaco F; Cullotta C; Mannino F; Bruno A; Squadrito F; Pallio G; Irrera N
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complementary and alternative medical therapies for children with attention-deficit/hyperactivity disorder (ADHD).
    Pellow J; Solomon EM; Barnard CN
    Altern Med Rev; 2011 Dec; 16(4):323-37. PubMed ID: 22214252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Alterations in the pattern of dopaminergic markers in attention-deficit/hyperactivity disorder].
    Díaz-Heijtz R; Mulas F; Forssberg H
    Rev Neurol; 2006 Feb; 42 Suppl 2():S19-23. PubMed ID: 16555214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Misinterpreting emotional expressions in attention-deficit/hyperactivity disorder: evidence for a neural marker and stimulant effects.
    Williams LM; Hermens DF; Palmer D; Kohn M; Clarke S; Keage H; Clark CR; Gordon E
    Biol Psychiatry; 2008 May; 63(10):917-26. PubMed ID: 18272140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults.
    Najib J
    Clin Ther; 2009 Jan; 31(1):142-76. PubMed ID: 19243715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.